Suchergebnisse - "Westin, Jason"

PubPharm (232)

1

Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

enthalten in: Leukemia & lymphoma | 2024

von Lionel, A. | Gurumurthi, A. | Fetooh, A. | +13

2

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy

enthalten in: American journal of hematology | 2024

von Lunning, M. | Wang, H. | Hu, Z. | +20

3

Impact of Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation in Non-Hodgkin Lymphoma

enthalten in: Blood advances | 2024

von Nze, C. | Andersen, C. | Ayers, A. | +12

4

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma : An open label, phase 2 study

enthalten in: Cancer | 2024

von Gordon, M. | Feng, L. | Strati, P. | +20

5

Outcomes of subsequent anti-lymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7

enthalten in: Blood advances | 2024

von Ghobadi, A. | Munoz, J. | Westin, J. | +13

6

Degradation trumps mutations in cancer

enthalten in: Science (New York, N.Y.) | 2024

von Davis, R. | Westin, J.

7

Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20+ B Cell Lymphoma

enthalten in: Transplantation and cellular therapy | 2024

von Munoz, J. | Flinn, I. | Cohen, J. | +9

8

Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

enthalten in: Blood cancer discovery | 2024

von Filosto, S. | Vardhanabhuti, S. | Canales, M. | +17

9

Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function

enthalten in: British journal of haematology | 2024

von Mamlouk, O. | Strati, P. | Feng, L. | +18

10

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma : An open label, phase 2 study

enthalten in: Cancer | 2024

von Gordon, M. | Feng, L. | Strati, P. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]